Search Results - "Kamble, Prasad G"
-
1
Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes
Published in Diabetologia (01-03-2021)“…Aims/hypothesis Results from animal models and some clinical work suggest a role for the central nervous system (CNS) in glucose regulation and type 2 diabetes…”
Get full text
Journal Article -
2
CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism
Published in Adipocyte (31-12-2023)“…Cdk5 and Abl enzyme substrate 1 (CABLES1) is a cell cycle regulator that has previously been identified as a candidate gene for obesity-related phenotypes, but…”
Get full text
Journal Article -
3
Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers
Published in Upsala journal of medical sciences (02-10-2017)“…Aim: To assess practical implications of genotype-based recall (GBR) studies, an increasingly popular approach for in-depth characterization of…”
Get full text
Journal Article -
4
Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes
Published in Molecular and cellular endocrinology (01-03-2020)“…We aim to investigate the expression of the glucagon receptor (GCGR) in human adipose tissue, and the impact of glucagon in glucose uptake and lipolysis in…”
Get full text
Journal Article -
5
Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes
Published in The journal of clinical endocrinology and metabolism (01-01-2019)“…The mechanism mediating sodium glucose cotransporter-2 (SGLT2) inhibitor-associated increase in glucagon levels is unknown. To assess short-term effects on…”
Get full text
Journal Article -
6
Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D
Published in The journal of clinical endocrinology and metabolism (01-07-2019)“…Abstract Context Roux-en-Y gastric bypass (RYGB) surgery effectively prevents or treats type 2 diabetes (T2D). Adipose tissue (AT) mechanisms may be of…”
Get full text
Journal Article -
7
Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women
Published in The journal of clinical endocrinology and metabolism (19-04-2022)“…Reduced estrogen levels in postmenopausal women predispose them to metabolic side effects, including insulin resistance and type 2 diabetes; however, the…”
Get full text
Journal Article -
8
Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes
Published in Obesity (Silver Spring, Md.) (01-03-2021)“…Objective This study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months…”
Get full text
Journal Article -
9
Estrogen interacts with glucocorticoids in the regulation of lipocalin 2 expression in human adipose tissue. Reciprocal roles of estrogen receptor α and β in insulin resistance?
Published in Molecular and cellular endocrinology (15-06-2019)“…The adipokine lipocalin 2 (LCN2) is linked to insulin resistance. Its expression in human adipose tissue (AT) can be regulated in a sex-specific manner by a…”
Get full text
Journal Article -
10
Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism
Published in Scientific reports (29-06-2020)“…CRISPR/Cas9 has revolutionized the genome-editing field. So far, successful application in human adipose tissue has not been convincingly shown. We present a…”
Get full text
Journal Article -
11
Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes
Published in The journal of clinical endocrinology and metabolism (01-10-2021)“…Abstract Context Roux-en-Y gastric bypass surgery (RYGB) markedly improves glycemia in patients with type 2 diabetes (T2D), but underlying mechanisms and…”
Get full text
Journal Article -
12
Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage
Published in Endocrine (01-10-2020)“…Purpose Obstructive sleep apnea (OSA) is associated with obesity and risk for type 2 diabetes. In this community-based study, we thoroughly investigated fatty…”
Get full text
Journal Article -
13
Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery
Published in Endocrine (01-02-2020)“…Objective To explore the role of hormones and the autonomic nervous system in the rapid remission of diabetes after Roux-en-Y Gastric Bypass (RYGB). Research…”
Get full text
Journal Article -
14
CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?
Published in Translational research : the journal of laboratory and clinical medicine (01-04-2022)“…CDKN2C/p18 (Cyclin-Dependent Kinase Inhibitor 2C) is a cell growth regulator that controls cell cycle progression and has previously been associated with…”
Get full text
Journal Article -
15
Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance
Published in Endocrine (01-03-2017)“…We recently showed that the peripheral cannabinoid receptor type 1 ( CNR1 ) gene is upregulated by the synthetic glucocorticoid dexamethasone. CNR1 is highly…”
Get full text
Journal Article -
16
Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue
Published in Molecular and cellular endocrinology (15-05-2016)“…The adipokine lipocalin 2 is linked to obesity and metabolic disorders. However, its role in human adipose tissue glucose and lipid metabolism is not explored…”
Get full text
Journal Article -
17
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
Published in Diabetes therapy (01-08-2018)“…Introduction The sodium-glucose cotransporter 2 inhibitor dapagliflozin and the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide reduce bodyweight…”
Get full text
Journal Article -
18
Palmitate impairs circadian transcriptomics in muscle cells through histone modification of enhancers
Published in Life science alliance (01-01-2023)“…Obesity and elevated circulating lipids may impair metabolism by disrupting the molecular circadian clock. We tested the hypothesis that lipid overload may…”
Get full text
Journal Article -
19
Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover
Published in Adipocyte (01-01-2018)“…The protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala polymorphism in type 2 diabetes (T2D) are unclear. We obtained…”
Get full text
Journal Article -
20
Regulation of Lipocalin 2 by Estrogen in Human Adipose Tissue—A Link between Erß Pathway and Insulin Resistance
Published in Diabetes (New York, N.Y.) (01-07-2018)“…We recently showed that the adipokine lipocalin 2 (LCN2) causes insulin resistance in human adipose tissue (AT). Its expression is induced by dexamethasone…”
Get full text
Journal Article